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Abstract
Background: Recent findings from a genome wide association investigation in a large cohort of patients with
Alzheimer’s disease (AD) and non demented controls (CTR) showed that a limited set of genes was in a strong
association (p > l0-5) with the disease.
Presentation of the hypothesis: In this report we suggest that the polymorphism association in 8 of these genes
is consistent with a non conventional interpretation of AD etiology.
Nectin-2 (NC-2), apolipoprotein E (APOE), glycoprotein carcinoembryonic antigen related cell adhesion molecule-
16 (CEACAM-16), B-cell lymphoma-3 (Bcl-3), translocase of outer mitochondrial membrane 40 homolog (T0MM-40),
complement receptor-1 (CR-l), APOJ or clusterin and C-type lectin domain A family-16 member (CLEC-16A) result in
a genetic signature that might affect individual brain susceptibility to infection by herpes virus family during aging,
leading to neuronal loss, inflammation and amyloid deposition.
Implications of the hypothesis: We hypothesized that such genetic trait may predispose to AD via complex and
diverse mechanisms each contributing to an increase of individual susceptibility to brain viral infections
Background
The incidence of Alzheimer’s disease (AD) is rising
sharply and a large fraction of the elderly population
will ultimately be affected by the disease. Because of an
urgent need for effective preventative and therapeutic
measures, extensive research has focused on pathoge-
netic mechanisms of the disease. However, effective
therapy is not already available. AD pathology is charac-
terized by neuronal loss leading to brain atrophy and a
decrement of the cerebral metabolism. Major neuro-
pathologic lesions are: (i) synapse and neuron loss; (ii)
extracellular amyloid deposits and amyloid plaques,
principally composed of amyloid beta (Ab) peptide; (iii)
intraneuronal accumulation of hyperphosphorylated Tau
proteins leading to neurofibrillary degeneration; (iv)
reactive astrogliosis; (v) brain inflammation. Current
views of AD pathogenetic mechanisms describe amyloid
deposition and neuritic plaque formation as a central
mechanisms leading to neuro-degeneration, cognitive
impairment and sporadic AD [1]. Therefore, therapeutic
approaches have focused on reducing amyloid load and
plaque deposition or clearance of brain amyloid. Other
mechanisms may be closely related with the etiology
and pathogenesis of sporadic AD.
Presentation of the hypothesis
Here we discuss recently published genetic data from a
genome wide association (GWA) study including several
thousand AD European patients and controls (CTR) [2]
and showing that a limited number of genes were highly
associated (p > l0-5) with the disease even after the
inclusion of additional data from control population
(stage 3 of GWA replication and statistical evaluation by
principal component adjustment [2]). The view pre-
sented here supports the notion of an infective etiology
for sporadic AD. The first set of genes was located in
close vicinity of the APOE locus on the chromosome 19
(see Table 1) and consisted of the poliovirus receptor-
related 2 or nectin-2 (NC-2), apolipoprotein E (APOE),
the translocase of outer mitochondrial membrane 40
homolog (TOMM-40), the glycoprotein carcinoembryo-
nic antigen related cell adhesion molecule-l6 (CEACAM-
l 6) and B-cell/lymphoma-3 (Bcl-3) genes. Genes in the
second set were located on different chromosomes: APOJ
or clusterin on chromosome 8; the complement receptor
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1 (CR-1), and C-type lectin domain family 16 member A
(CLEC-16A) on chromosome 16. Polymorphic variations
in each of these genes were individually associated with
AD (P values ranging from l0-16 to 10-5). However we
argue that the concomitant presence of several poly-
morphisms of these genes in the same individual might
represent a genetic signature of AD. In this report we
hypothesized that such a genetic trait may predispose to
AD via complex and diverse mechanisms each contribut-
ing to an increase of individual susceptibility to brain
viral infections. The evidence supporting this new notion
are briefly listed below.
1) NC-2, also known as herpes virus entrance-B
(HveB) or poliovirus receptor-relate protein-2 (PVRL-2
or Prr2), is a member of the immunoglobulin superfam-
ily, is expressed in a variety of cell tissues, including
neurons, belongs to the cadherin adhesion molecules [3]
and mediates the entry of herpes simplex viruses (HSV)
[4]. The glycoprotein D (gD) of HSV is the ligand for
NC-2 and one of several HSV binding proteins that are
essential for fusion to the human target cell and viral
entering [4]. Gene variants in the human NC-2 gene
might affect individual susceptibility to HSV infection of
the brain by influencing virus cell entry and cell-to cell
virus spreading.
2) APOE 4 allele is a well established genetic risk fac-
tor for AD and it has been also confirmed in the Eur-
opean GWA study [2]. ApoE protein may affect Ab
deposition. However, APOE 4 allele has been also
shown to influence: susceptibility to viral infections [5],
human immune deficiency virus (HIV) cell entry
in vitro, HIV disease clinical progression [6], recurrent
genital herpes in patients co-infected by HSV-2 and
HIV [7] and progression of experimental ocular lesions
induced by HSV-1 [8]. Therefore, APOE 4 allele associa-
tion with AD might also influence the susceptibility to
virus entry and spreading into neuronal cells. On the
other hand, APOE 4 allele seems to be protective in the
case of liver damage caused by HCV [9].
3) TOMM-40 gene codes for a mitochondrial translo-
case. It is interesting to note that HSV DNAase such as
the UL12.5 enzyme destroys the mitochondrial genome
[10] by inducing rapid and complete degradation of
mitochondrial DNA [11]. Gene variations at TOMM-40
gene might influence DNA digestion and mitochondrial
damages induced by HSV DNAase and other less
defined virus dependent mechanisms.
4) CEACAM-16 belongs to a family of gene coding for
adhesion molecules related to cancer replication, such as
the carcinoembryonic antigen (CEA), and has been
recently shown to regulate apoptosis in early tumor
development by affecting caspase-l/3 activation [12].
5) Bcl-3 is an oncogene and is also involved in cell
replication and apoptosis. Apoptosis may act as a primi-
tive immune response and is a potent host defense
mechanism. It is known that HSV is able to both induce
Table 1 Genes cluster surrounding the APOE gene on human chromosome 19 Region: 45,120K-45,710 K bp
Start Stop Symbol Cyto Description
45116956 45138792 LOC147710 19 hypothetical LOC147710
45147098 45169429 PVR 19q13.2 poliovirus receptor
45174724 45187627 CEACAM19 19 carcinoembryonic antigen-related cell adhesion molecule 19
45202358 45213986 CEACAM16 19 carcinoembryonic antigen-related cell adhesion molecule 16
45251978 45263301 BCL3 19q13.1-q13.2 B-cell CLL/lymphoma 3
45281126 45303903 CBLC 19q13.2 Cas-Br-M (murine) ecotropic retroviral transforming sequence c
45312338 45324678 BCAM 19q13.2 basal cell adhesion molecule (Lutheran blood group)
45349393 45392485 PVRL2 19q13.2 poliovirus receptor-related 2 (herpesvirus entry mediator B)
45394477 45406946 TOMM40 19q13 translocase of outer mitochondrial membrane 40 homolog (yeast)
45409039 45412650 APOE 19q13.2 apolipoprotein E
45411802 45431701 LOC100129500 19 hypothetical LOC100129500
45417921 45422606 APOC1 19q13.2 apolipoprotein C-I
45430017 45434450 APOC1P1 19q13.2 apolipoprotein C-I pseudogene 1
45445495 45448751 APOC4 19q13.2 apolipoprotein C-IV
45449243 45452818 APOC2 19q13.2 apolipoprotein C-II
45458638 45496599 CLPTM1 19q13.2-q13.3 cleft lip and palate associated transmembrane protein 1
45504712 45541452 RELB 19 v-rel reticuloendotheliosis viral oncogene homolog B
45542298 45574214 SFRS16 19q13.3 splicing factor, arginine/serine-rich 16
45574758 45579688 ZNF296 19 zinc finger protein 296
45582518 45594782 GEMIN7 19 gem (nuclear organelle) associated protein 7
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and suppress apoptosis in infected cells. In particular
HSV-1 was shown to inhibit initially induced apoptosis
in neuronal cells via a caspase-3 dependent pathway
[13]. Moreover, Bcl-2 protein was able to block HSV-1
induced apoptosis in human hepatocytes [14]. Therefore,
gene polymorphism in both CECAM-16 and Bcl-3 genes
might influence individual susceptibility to apoptosis
regulation induced by HSV and favor virus spreading in
the central nervous system (CNS).
6) The APOJ, also known as clusterin, is a modulator
of complement activation. Complement biosynthesis and
activation occurs in neurodegenerative diseases such as
AD [15] and the cytolytic activity of complement com-
ponents is important for virus neutralization. ApoJ is
synthesized in the CNS and is present in amyloid pla-
ques [16]. Polymorphism in APOJ gene might influence
virus lytic defences by regulation of complement
activation.
7) CR1 is a complement receptor which bind different
complement components (C3b, C3 d, C2a). Herpes
virus family (especially alpha herpes) expresses a mem-
ber of gC protein family that is able to bind heparan
sulphate and the C3b component of the complement
system [4]. Genetic variation in CR1 and CR2 receptors
might affect individual capacity of virus clearance via C3
activation and C3b binding to the HSV. APOJ and CR1
genes might be illustrated as a synergistic gene cluster
and influence brain virus defences such as complement
activation, virus lysis and clearance.
8) CLEC-16A gene codes for a C-type lectin domain
receptor. Lectin-like receptor, such as mannose receptor,
recognizes and binds sugar moieties on pathogen glyco-
proteins. No data are on record regarding CLEC-16A
and HSV or other viruses. However, gene polymorphism
in the CLEC-16A gene might influence individual ability
to recognize and bind virus glycoproteins.
Implications the hypothesis
The genetic signature here discussed is suggestive of
individual susceptibility to pathogen infection of the
brain, particularly HSV and related viruses. Recently, an
independent investigation in late-onset sporadic AD
from Japan also showed that gene variations near the
APOE locus (PVRL-2, APOE 4 allele and APOC1) on
chromosome 19, were associated with increased risk for
the disease [17]. These independent findings appear to
reinforce the new notion that individual brain suscept-
ibility to virus infection and/or reactivation may be one
complex genetic trait influencing the risk of neurode-
generation leading to clinical AD in old age. Moreover,
evidence from other investigators showing HSV infec-
tion in AD brains are on record [18-20]. It is of interest
that the concomitant presence of the APOE 4 allele and
vertical transmission of HSV-1 has been shown to
confer a differential risk of brain infection and AD [21].
Moreover, APOE 4 deficient mice had significantly
lower virus load in CNS than APOE 4 transgenic mice
[22]. In addition, in transgenic mouse model, APOE4
was shown to be a risk factor for ocular herpes favoring
increased HSV-1 intra ocular replication [23].
Reactivation of HSV-1 in the brain was also found in
patients with familial AD who showed increased viral
DNA and protein expression in cortical neurons [24].
HSV-1 has been also related to Down’s syndrome, a
condition at high risk for AD type dementia [25]. It is of
interest that mothers of children with Down’s syndrome
showed increased serum HSV-2 antibody levels [26].
Viruses of the HSV family are among the most probable
pathogen candidates for brain reactivation in old age,
since their possess a well known ability to escape per-
ipheral immune responses by invading neurons. It is of
interest that during aging a substantial proportion of
peripheral CD8 T cytotoxic cells have been found to be
directed against Epstein-Barr virus (EBV) and cytomega-
lovirus (CMV), which belong to the HSV family. More-
over, it has been suggested that aged immune system is
no longer able to control EBV or CMV reactivation [27]
and virus infection might become chronic in a large
proportion of the elderly. Therefore, we speculate that
with advancing age an impaired immune system might
facilitate virus reactivation in the brain, especially in
those subjects showing the above suggested genetic sig-
nature. Latent or chronic viral infection by CMV has
been indeed found to correlate with the rate of cognitive
decline in the Sacramento Area Latino Study on Aging
[28]. Another study, focused on elderly with cardiovas-
cular disease, showed that HSV and CMV burden was
associated with cognitive impairment [29].
Therefore, brain infection by reactivated latent viruses
might be one of the primus movens inducing progressive
neuronal loss, astro-glia activation, and, by impairing
APP transport along the axons [19], APP dis-appropriate
metabolism and amyloid deposition.
This hypothesis is partially supported by data from
HIV positive patients under protease inhibitor treatment
and without encephalitis, where Ab amyloid brain
deposition was a common neuropathological feature
[30]. Moreover it has been showed that APP, a putative
receptor for the microtubule motor named kinesin, is a
major component of viral HSV-1 particles, as abundant
as any viral encoded protein [31].
These findings indeed showed that a brain virus infec-
tion could induce amyloid deposition. Another GWA in
AD from Europe and USA recently confirmed the asso-
ciation of TOMM-40, PVRL-2, APOJ and APOE with
AD. This investigation also signaled a significant asso-
ciation of the phosphatidilinositol-binding clathrin
assembly protein gene (PICALM) with AD [32]. It is of
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interest that clathrin (CLA) mediated endocytosis is
involved in internalization and transportation of viruses
into the infected cell and to the nucleus. For instance,
human rhinovirus is internalized by a CLA dependent
mechanism [33] and adenovirus transport into motor-
neuron axons is mediated via CLA endocytosis [34].
Insect parvovirus particles were also shown to be rapidly
internalized into CLA-coated vesicles and slowly moved
within early and late endocytic compartments to the
nucleus [35]. Moreover, varicella herpes zoster virus was
shown to interfere with intracellular trafficking by inter-
acting with CLA-coated vesicles for subsequent trans-
portation to endosomes [36]. Data from this
independent GWA in AD patients also seem to support
the presence of a genetic signature suggestive of a viral
risk factor in AD. Finally recent data, reporting that Ab
peptide showed an anti-microbial activity [37] and acted
as a defense molecule of the innate immunity, is compa-
tible with the hypothesis of viral association with AD
etiology and pathogenesis. The accumulation of Ab and
plaque deposit may derive by an over-production of Ab
peptides directed against a viral invader of the brain.
Moreover, some evidence is on record showing that
HSV1 can directly contribute to the processing of Ab
and to the development of senile plaques and a Ca(2+)
dependent APP phosphorylation and Ab 42 accumula-
tion in rat cortical neurons [38,39].
Two recent meta-analysis from GWA [40,41] con-
firmed APOE, CLU, PICALM and CR-1 as susceptibility
genes for AD risk. Therefore, this genetic trait in asso-
ciation with the other above discussed genes might
represent a gene cluster affecting AD risk by influencing
virus infection susceptibility. Our hypothesis describes a
set of gene upstream of the APOE locus on chromo-
some 19 spanning from CEACAM-19 to APOE (as
shown in Table 1) that may constitute a gene cluster of
susceptibility for AD by affecting different mechanism
involved in virus entrance or resistance to virus infec-
tion. CLU/APOJ, CR-1 and CLEC-16 genes located on
different chromosome complement the AD susceptibility
gene cluster also by affecting virus entry and cellular
defense mechanism. It is interesting to note that SNPs
upstream of APOE locus spanning from TOMM-40 to
APOE promoter may also play a role in AD risk by
affecting APOE expression in AD brain [42]. Moreover
a genetic association study also confirmed that PVRL-2
(Nec-2), TOMM-40, APOE and APOC1 predispose to
AD and showed that this region is firmly sandwiched
between two recombination hotspots [17]. Therefore,
the APOE ε4 might represent a genetic beacon of this
set of genes located in its proximity on chromosome 19.
Our hypothesis confirm and extend to other genes, a
recent suggestion indicating that APP, APOE, CR-1,
CLU and PICALM genes may be involved in HSV life
cycle [43]. In conclusion, present findings suggest that
during ageing virus reactivation may be more frequent
in the elderly showing a genetic signature predisposing
to an increased susceptibility for HSV and other virus
infections of the brain. In these subjects the microorgan-
isms are more likely to induce a limited, segmental and
chronic sub-clinical pseudo-encephalitis resulting in
progressive neurodegeneration. Further investigations
will validate or refute this innovative approach to
dementia in old age and clarify whether the presence of
HSV and/or other infectious agents in the CNS repre-
sents a causative factor or a secondary infection in AD.
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